ETrade Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $2.26M | Sell |
8,294
-770
| -8% | -$210K | 0.04% | 208 |
|
|
2020
Q2 | $2.63M | Sell |
9,064
-107
| -1% | -$31.1K | 0.05% | 184 |
|
|
2020
Q1 | $2.18M | Buy |
9,171
+75
| +0.8% | +$17.8K | 0.06% | 182 |
|
|
2019
Q4 | $1.99M | Sell |
9,096
-378
| -4% | -$82.7K | 0.04% | 213 |
|
|
2019
Q3 | $1.61M | Sell |
9,474
-915
| -9% | -$155K | 0.04% | 242 |
|
|
2019
Q2 | $1.91M | Buy |
10,389
+291
| +3% | +$53.4K | 0.05% | 215 |
|
|
2019
Q1 | $1.86M | Sell |
10,098
-1,799
| -15% | -$331K | 0.05% | 215 |
|
|
2018
Q4 | $1.97M | Buy |
11,897
+65
| +0.5% | +$10.8K | 0.06% | 172 |
|
|
2018
Q3 | $2.28M | Buy |
11,832
+790
| +7% | +$152K | 0.07% | 173 |
|
|
2018
Q2 | $1.88M | Buy |
11,042
+603
| +6% | +$103K | 0.06% | 191 |
|
|
2018
Q1 | $1.7M | Sell |
10,439
-738
| -7% | -$120K | 0.05% | 208 |
|
|
2017
Q4 | $1.68M | Buy |
11,177
+1,874
| +20% | +$281K | 0.05% | 212 |
|
|
2017
Q3 | $1.41M | Buy |
9,303
+819
| +10% | +$124K | 0.05% | 223 |
|
|
2017
Q2 | $1.09M | Buy |
8,484
+1,596
| +23% | +$206K | 0.04% | 243 |
|
|
2017
Q1 | $753K | Buy |
6,888
+1,601
| +30% | +$175K | 0.03% | 348 |
|
|
2016
Q4 | $389K | Buy |
5,287
+1,636
| +45% | +$120K | 0.02% | 439 |
|
|
2016
Q3 | $318K | Buy |
3,651
+714
| +24% | +$62.2K | 0.02% | 442 |
|
|
2016
Q2 | $253K | Buy |
2,937
+401
| +16% | +$34.5K | 0.01% | 429 |
|
|
2016
Q1 | $202K | Buy |
2,536
+491
| +24% | +$39.1K | 0.01% | 442 |
|
|
2015
Q4 | $257K | Buy |
+2,045
| New | +$257K | 0.02% | 399 |
|
|
2013
Q4 | – | Sell |
-9
| Closed | -$1K | – | 914 |
|
|
2013
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 898 |
|